Syschem (India) Ltd.
Snapshot View

24.60 +1.15 ▲4.9%

27 June 2022, 04:01:00 PM
Volume: 30,004

Overview View Details

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.syschem.in
Market Cap 61.60 Cr.
Enterprise Value(EV) 62.97 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) -0.68 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-03
Industry PE 29.84 Trailing Twelve Months Ending 2022-03
Book Value / Share 3.51 Trailing Twelve Months Ending 2022-03
Price to Book Value 7.00 Calculated using Price: 24.60
Dividend Yield 0.00 Period Ending 2021-03
No. of Shares Subscribed 2.50 Cr. 25,040,400 Shares
FaceValue 10
Company Profile
Syschem India was incorporated on December 31, 1993 as Anil Pesticides and obtained certificate of commencement of business on February 1, 1994. The company is promoted by Anil Nibber, Atul Nibber and Ajay Kumar Singla.

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
+4.90%
1 Week
+4.90%
1 Month
+46.95%
3 Month
+105.00%
6 Month
+69.42%
1 Year
+207.50%
2 Year
+249.93%
5 Year
+73.00%
10 Year
+79.56%
9 years 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03
Return on Equity (%) 7.66 4.37 -32.44 -25.21 -19.78 4.43 7.67 -17.24 -66.17
Return on Capital Employed (%) 7.76 7.88 -10.60 -8.30 -6.68 2.68 5.51 -8.22 -29.75
Return on Assets (%) 2.50 1.16 -7.41 -4.69 -3.41 0.69 1.30 -3.06 -8.28

Balance Sheet View Details

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03* Rs. Cr.
Shh. Funds 14 15 11 9 7 9 12 10 7 7
Non Curr. Liab. 22 22 20 19 13 12 11 12 26 23
Curr. Liab. 11 17 19 18 22 34 37 39 41 26
Minority Int.
Equity & Liab. 48 55 50 45 42 56 61 61 74 56
Non Curr. Assets 36 37 35 33 31 30 28 30 32 32
Curr. Assets 12 17 15 13 11 26 32 31 42 24
Misc. Exp. not W/O
Total Assets 48 55 50 45 42 56 61 61 74 56

Profit Loss View Details

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. TTM
Net Sales 16 18 11 4 13 67 93 77 68 66
Other Income 0 1 0 0 0 0 0 0
Total Income 16 20 11 4 13 67 93 77 69 66
Total Expenditure -12 -14 -14 -5 -13 -63 -90 -77 -74 -65
PBIDT 4 5 -3 -1 0 3 4 0 -5 1
Interest -1 -3 -1 0 0 0 0 0 0 0
Depreciation -1 -2 -2 -2 -2 -2 -2 -2 -2 -3
Taxation 0 0 1 1 1 0 -1 0 2 0
Exceptional Items 0
PAT 1 1 -4 -2 -1 0 1 -2 -6 -2
Adjusted EPS 1 0 -2 -1 -1 0 0 -1 -3 -1

Cash Flow View Details

Particulars 10 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 0 4 4 1 0 6 0 -2 3 4
Cash Fr. Inv. -14 -13 -3 0 0 0 0 2 -4 -4
Cash Fr. Finan. 15 10 -1 -2 -1 -7 0 0 0 0
Net Change 0 1 0 -1 0 0 0 0 0 0
Cash & Cash Eqvt 0 1 1 0 0 0 0 0 0 0

Shareholding Pattern View Details

9 Qtrs 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%)
Promoter 10.50 10.54 9.54 9.54 9.54 9.54 16.34 16.34 16.34
Public 89.49 89.46 90.46 90.46 90.46 90.46 83.66 83.66 83.66
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 20.28 20.20 19.47 19.47 19.47 19.47 10.51 10.51 0.00

Announcements View Details

Tue, 21 Jun 2022
Disclosure of Voting results of EGM (Regulation 44(3) of SEBI (LODR) Regulations 2015)
Syschem India Ltd has informed BSE regarding the details of Voting results of EGM under Regulation 44(3) of SEBI (LODR) Regulations 2015. Kindly Click here
Sat, 18 Jun 2022
Declaration Of The Voting Results Of The Extra-Ordinary General Meeting Of The Company Held On 17Th June 2022 Along With Scrutinizer Report
Pursuant to Regulation 44 (3) of SEBl (Listing Obligations & Disclosure Requirements) Regulations 2015 please find enclosed herewith the details of the Voting Results of the Extra-ordinary General Meeting (EGM) held on 17th June 2022 as per the prescribed format.Further as required under Section 108 & 109 of the Companies Act 2013 read with Rule 20 & 21 of the Companies (Management and Administration) Rules 2014 as amended from time to time the report of the Scrutinizer on remote e-voting process is also enclosed herewith.As per the Report the resolutions are passed with requisite majority.
Fri, 17 Jun 2022
Outcome And Proceedings Of Extra-Ordinary General Meeting Of The Company Held On 17.06.2022
Pursuant to Regulation 30 read with part A of Schedule III of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 we wish to inform you that Extra-Ordinary General Meeting was held on Friday 17th June 2022 at 11.30 A.M. through electric mode (Video Conferencing (VC) / Other Audio Visual Means (OAVM)) and concluded at 11.52 A.M.The Scrutinizers Report and the details of the result of voting will be submitted to the exchange within the stipulated time.The summary of the proceedings of EGM is enclosed for your records.

Technical Scans View Details

Mon, 27 Jun 2022
Opening at High Opening at High
Opening at Low Opening at Low
Closing Above Previous High Closing Above Previous High
Close Within 52 Week High Zone Close Within 52 Week High Zone
Increasing Relative Strength - Sectoral Index Increasing Relative Strength - Sectoral Index

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 200,572.41 835.95 +1.4%
Divi's Laboratories Ltd. 97,518.56 3,679.05 0.0%
Cipla Ltd. 75,086.75 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. 71,855.08 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. 54,559.09 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. 48,438.53 2,858.25 -0.6%
Gland Pharma Ltd. 43,775.42 2,658.60 +0.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 61.29 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2022-03 32.99 3,679.05 0.0%
Cipla Ltd. Consolidated 2022-03 29.83 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 32.92 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 51.70 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 62.24 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2022-03 36.13 2,658.60 +0.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 4.18 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2022-03 8.33 3,679.05 0.0%
Cipla Ltd. Consolidated 2022-03 3.60 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 3.74 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 9.68 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8.12 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2022-03 6.12 2,658.60 +0.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 0.08 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 0.00 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 0.10 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 0.17 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 0.62 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 0.84 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2021-03 0.00 2,658.60 +0.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 4.98 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 23.90 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 14.13 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 3.44 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 23.49 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2021-03 20.97 2,658.60 +0.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 4.98 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 23.90 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 14.13 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 3.44 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 23.49 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2021-03 20.97 2,658.60 +0.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 33,498.14 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 6,969.40 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 19,159.59 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 19,047.50 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 10,560.00 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 8,004.83 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2021-03 3,462.88 2,658.60 +0.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 2,284.68 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 1,984.29 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 2,401.30 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 1,903.60 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 136.00 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 1,251.88 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2021-03 996.96 2,658.60 +0.6%

FAQ's On Syschem (India) Ltd.

Can I Buy Syschem (India) Shares now?

What is the Share Price of Syschem (India)?

What is the Relative Strength Index (RSI) Value of Syschem (India)?

What is the Market Capital (MCAP) of Syschem (India)?

What are the key metrics to analyse Syschem (India)?

What is the Price Performance of Syschem (India)?